Tataka, Yusei
Kawashima, Hitoshi
Nanri, Hinako
Watanabe, Daiki
Watanabe, Kenji
Yamaguchi, Masaya
Kunisawa, Jun
Miyachi, Motohiko https://orcid.org/0000-0002-1146-0905
Funding for this research was provided by:
Development of Innovative Research on Cancer Therapeutics from the Japan Agency for Medical Research and Development (JP16ck0106243h0001)
Grant-in-Aid for Scientific Research C (JP16K00944)
Health and Labor Sciences Research Grant (201709002 B)
Article History
Received: 24 October 2025
Accepted: 23 July 2026
First Online: 1 August 2026
Declarations
Ethics approval and consent to participate: This study was approved by the Ethics Committee of the NIBN (approval no. KENEI3-12) and was registered in the University Hospital Medical Information Network Clinical Trials Registry (UMIN-CTR, registration no. UMIN000023270). All participants provided written informed consent after receiving a thorough explanation of the study procedures and potential risks prior to the commencement of data collection.
Consent for publication: Not applicable.
Competing interests: The authors declare no competing interests.